NASDAQ:CDT

Conduit Pharmaceuticals (CDT) Stock Price, News & Analysis

$2.97
+0.03 (+1.02%)
(As of 05/17/2024 06:55 PM ET)
Today's Range
$2.66
$3.05
50-Day Range
$2.82
$3.68
52-Week Range
$0.95
$25.00
Volume
26,800 shs
Average Volume
33,474 shs
Market Capitalization
$219.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CDT stock logo

About Conduit Pharmaceuticals Stock (NASDAQ:CDT)

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

CDT Stock Price History

CDT Stock News Headlines

Conduit Pharmaceuticals Adds Key Leadership Positions
Conduit Pharmaceuticals Opens New Laboratory in UK
Conduit Pharmaceuticals Inc. (CDT)
Conduit Pharmaceuticals Inc. (CDTTW)
Conduit Pharmaceuticals Inc.
KXIN and ICU among pre-market losers
CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc (CDT)
See More Headlines
Receive CDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/20/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CDT
Previous Symbol
NASDAQ:CDT
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.01) per share

Miscellaneous

Free Float
56,487,000
Market Cap
$219.28 million
Optionable
Not Optionable
Beta
2.52
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. David Joszef Tapolczay (Age 65)
    CEO & Director
    Comp: $419.8k
  • Mr. Adam Sragovicz (Age 54)
    Chief Financial Officer
    Comp: $116.67k
  • Dr. Joanne M. Holland (Age 49)
    Chief Scientific Officer

CDT Stock Analysis - Frequently Asked Questions

How have CDT shares performed in 2024?

Conduit Pharmaceuticals' stock was trading at $4.55 on January 1st, 2024. Since then, CDT stock has decreased by 34.7% and is now trading at $2.97.
View the best growth stocks for 2024 here
.

When is Conduit Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our CDT earnings forecast
.

How do I buy shares of Conduit Pharmaceuticals?

Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CDT) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners